Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss How to Initiate Heart Failure Drugs February 16, 2021 Disclosures: TBA
Heart Success: Dr. Carolyn Lam and Dr. C. Michael Gibson Talk About Success in the Battle Against Heart Failure November 20, 2020 Disclosures: TBA
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients October 17, 2020 Disclosures: TBD
Dr. Damien Collison and Dr. C. Michael Gibson Discuss: TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization October 16, 2020 Disclosures: TBD
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: Disrupt CAD III: Safety and Effectiveness of Intravascular Lithotripsy for Treatment of Severe Coronary Calcification October 16, 2020 Disclosures: TBD
Dr. Junjie Zhang and Dr. C. Michael Gibson Discuss: ULTIMATE: Three-Year Outcomes After IVUS-Guided vs Angiography Guided DES Implantation October 15, 2020 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2020 Daily Wrap-Up – October 15, 2020 October 15, 2020 Disclosures: TBD
Dr. Jeffrey Moses and Dr. C. Michael Gibson Discuss: REFLECT II: A Randomized Trial of a Cerebral Embolic Protection Device During TAVR October 15, 2020 Disclosures: TBD
Dr. Ajay Kirtane, Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: TCT 2020 Daily Wrap-Up – October 14, 2020 October 14, 2020 Disclosures: TBD
